THOMAS BOLAND is a Professor in the Department of Metallurgy and Materials Engineering at the University of Texas at El Paso. He also serves as the director of UTEP's Biomedical Engineering Program. He received his B.S. in Chemical Engineering from the Ecole Nationale Sup‚rieure d'Ing‚nieurs de Genie Chimique in Toulouse, France in 1990, and his Ph.D. in Chemical Engineering from the University of Washington, Seattle, WA in 1995. In 1994, he was a finalist for the Materials Research Society Graduate Student Award. Following his Ph.D., he was a Postdoctoral Fellow at Department of Materials Science at the Pennsylvania State University from 1995-1997, and at the Naval Research Laboratory from 1997-1999. In 1999, he joined Clemson University as Assistant Professor, where he received tenure in 2005. Prior to heading up the UTEP BME program, Thomas was the Director of a NSF/NIH funded Bioengineering and Bioinformatics Summer Institute, whose primary mission is to introduce senior undergraduate and junior graduate students with science and engineering backgrounds to the interdisciplinary research projects in the bioengineering and bioinformatics areas. Thomas' research interests are applying engineering principles to automate, predict and build three dimensional structures with that show biological function. He has received numerous awards and was featured on CNN and the Discovery Channel for his ground breaking innovations using inkjet printers to assemble cells and biomaterials into viable and functioning structures. He is the author of more than 45 publications, including 3 invited reviews and chapters, and he has delivered more than 25 invited presentations. He is a member of the AVS, MRS, the Society for Imaging Science and Technology (IS&T) and the Tissue Engineering and Regenerative Medicine International Society (TERMIS).

• Hometown Hero - Oscar Arrieta Agency, Allstate (01/29/2022)
• Fellow - National Academy of Inventors (12/09/2021)
• Fellow - Biomedical Engineering Society (10/01/2018-10/31/2018)
• Fellow - American Institute of Medical and Biological Engineering (09/01/2010-09/30/2010)

• Materials Science/Chemistry, Pennsylvania State University (1998)
• Ph D in Chemical Engineering, University of Washington (1995)
• Ph D in Chemical Engineering, University of Washington (1995)
• BS in Chemical Engineering, Ecole Nationale Supérieure d’Ingénieurs de Génie Chimique (1990)
• BS in Chemical Engineering, Ecole Superieure d'Ingenieurs de Genie Chimique (1990)

• Thermal Inkjet Bioprinting Drastically Alters Cell Phenotype Biofabrication 15 3 (2023), Patricia Ablanedo Morales, Brittany Rodriguez, Michael Furth, Kayla Molina, Andrew Boland, Jonathon E. Mohl, Thomas Boland.
• Thermal inkjet bioprinting drastically alters cell phenotype Biofabrication 15 3 (2023), Thomas Boland.
• Detection of Anticancer Drug-Induced Cardiotoxicity Using VCAM1-Targeted Nanoprobes ACS Applied Materials & Interfaces 14 33 (2022), Humayra Afrin, Md N. Huda, Tamanna Islam, Beu P. Oropeza, Efren Alvidrez, Muhammad I. Abir, Thomas Boland, David Turbay, Md Nurunnabi.
• Photocleavable nitroindoline-based crosslinkers (2022), Katja Michael, Chunqlang Li, Thomas Boland, Hector P. Del Castillo Vazquez, Binata Joddar, Alfredo O. Sanchez, Javier H. Ortega, Irodiel V. Lozano, Philip T. Baily.
• Generating induced pluripotent stem cells (2022), Thomas Boland.

• Project ACE: Action for Equity (2022), Osvaldo F. Morera, Thomas Boland, Josefina V. Tinajero.
• Bioprinted Breast Cancer Models: New Molecular Insights and Potential Drug Targets (2020), Thomas Boland, Jonathon E. Mohl, Armando Varela.
• Advances in 3D breast tissue fabrication for drug development and tissue reconstruction (2020), Thomas Boland, .
• Microscopic Characterization of Inkjet Printed Fibroblasts (2020), Brittany Rodriguez, Thomas Boland.
• Bioprinted Aortic Construct for Pediatric Congenital Defect Repair (2020), Beu Oropeza, Thomas Boland.

• Project ACE -- Action for Equity: a Building Scholars Pipeline
• I-Corps Sites: Type I - University of Texas at El Paso I-Corps Site for Innovation